Witnessing her daughter desperately gasping for breath had become a normal, if terrifying, feature of Sophie Hafford's life.
A new add-on therapy administered every six months targets key inflammatory pathways in asthma and chronic rhinosinusitis ...
Data from Asthma and Lung UK reveals that 7.2 million people in the UK have asthma, equating to roughly eight in every 100 individuals. Those with asthma may experience symptoms such as wheezing, ...
Data from Asthma and Lung UK reveals that 7.2 million people in the UK have asthma, equating to roughly eight in every 100 ...
New draft guidance recommends using eight apps on the health service for the next three years while further evidence is ...
More must be done to ensure that asthma patients get access to cutting-edge treatments, experts have said, after research found that 66% of eligible patients are not receiving gold standard care.
Coughing and wheezing can leave anyone wondering whether it is asthma or bronchitis at play. Both of these respiratory issues share symptoms but have different roots: one is a chronic condition, ...
Depemokimab 'has the potential to redefine care for millions of patients' A ‘LIFE-SAVING’ jab for severe asthma that could prevent deadly attacks with just two doses a year could be available to ...
An asthma treatment that only requires patients to have two jabs a year to prevent life-threatening attacks will be available in Britain. Pharmaceutical giant GSK has been granted marketing ...
It’s the time of year when coughs and colds run rampant - and everyone appears to be getting ill. But health experts have warned that this winter could be one of the worst yet, with the most severe ...
A new option for hard-to-control asthma: The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma. Designed to reduce flare-ups: The injectable ...
Following the recent update to the National Institute of Care Excellence (NICE) guidelines for asthma care and management, Bedfont ® Scientific Limited sponsored an informative webinar by Intermedical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results